Section Arrow
GBIO.NASDAQ
- Generation Bio Co
Quotes are at least 15-min delayed:2026/01/09 09:41 EST
Regular Hours
Last
 5.42
-0.09 (-1.63%)
Day High 
5.5 
Prev. Close
5.51 
1-M High
5.77 
Volume 
721 
Bid
5.35
Ask
5.49
Day Low
5.42 
Open
5.5 
1-M Low
5.2001 
Market Cap 
37.13M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.53 
20-SMA 5.48 
50-SMA 5.38 
52-W High 10.4 
52-W Low 3.004 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-9.37/0.64
Enterprise Value
117.68M
Balance Sheet
Book Value Per Share
7.50
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
19.89M
Operating Revenue Per Share
0.13
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IBIOiBio2.6517+0.3017+12.84%0.65PE
SLSSELLAS Life Sciences Group3.48-0.38-9.84%-- 
ARDXArdelyx7.565+0.565+8.07%-- 
ABSIAbsci Corp3.35-0.09-2.62%-- 
ALLOAllogene Therapeutics1.79+0.3+20.13%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.